目的探讨在择期经皮冠状动脉介入（PCI）治疗中静脉应用伊诺肝素的有效性和安全性以及与普通肝素对比的疗效差别。
Objective To investigate the effectiveness and safety of intravenous enoxaparin application in PCI and its therapeutic effect compared with unfractionated heparin.
不管是否服用氯吡格雷，依诺肝素都较普通肝素具有更明显的安全性和有效性。
The significantly improved safety and efficacy profile of enoxaparin versus unfractionated heparin was maintained regardless of clopidogrel administration.
这些研究比较了血液稀释剂普通肝素和安慰剂、低分子肝素和安慰剂或是两种肝素之间的作用比较。
The studies compared the blood-thinner unfractionated heparin to a placebo, or low-molecular-weight heparin with a placebo, or both types of heparin with each other.
应用推荐